Status:
COMPLETED
Cardiomyopathy Following Stem Cell Transplantation
Lead Sponsor:
National Institutes of Health Clinical Center (CC)
Conditions:
Cardiomyopathy
Eligibility:
All Genders
18-80 years
Brief Summary
This study will examine the incidence of cardiac complications, particularly cardiomyopathy, in patients who have undergone allogeneic (donor) stem cell transplantation at NIH. Cardiac complications i...
Detailed Description
Cardiac complications in patients who have undergone allogeneic hematopoietic stem cell transplantation (HSCT) have been well documented. Most commonly patients present with congestive heart failure a...
Eligibility Criteria
Inclusion
- ELIGIBILITY CRITERIA:
- Patients who have undergone an allogeneic HSCT on either an NHLBI or NCI protocol since 1999 will be the patient population for this chart review. Patients with documented serious cardiac events will be identified from NHLBI cardiology consult records, NCI and NHLBI research data bases, and the data base of the echocardiogram service.
Exclusion
Key Trial Info
Start Date :
May 2 2006
Trial Type :
OBSERVATIONAL
End Date :
May 16 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00352209
Start Date
May 2 2006
End Date
May 16 2007
Last Update
July 2 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892
2
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892